MeCure secures 10% equity from Zrosk amid funding hurdles

MeCure Industries Plc has strengthened its position with a 10 per cent equity investment from Zrosk Investment Management Limited. This strategic move comes amid a challenging funding landscape in Nigeria, where healthcare businesses increasingly seek alternative sources of capital to mitigate the impact of high borrowing costs. Last week, the Central Bank of Nigeria raised its benchmark interest rate from 26.75 per cent in August 2024 to 27.25 per cent in October 2024, raising the cost of borrowing to a record level. MeCure in an anno